Stem Cell Innovations to Supply PluriCells™ to Stanford University Researchers
Complete the form below to unlock access to ALL audio articles.
Stem Cell Innovations has announced that it has signed an agreement to supply PluriCells™ to researchers at Stanford University.
Under the agreement, investigators at Stanford may receive the cells for use in their laboratories.
Stem Cell Innovations PluriCells™ provide an alternative to ES cells and are available for broad based government funding.
The company has previously presented data demonstrating its ability to grow PluriCells™ efficiently and reproducibly without feeder layers, and believes they can serve as an attractive alternative to embryonic stem cells (ES) in federally funded labs.
"We are very pleased to have concluded this agreement with Stanford, home to several of the leading stem cell scientists, and expect to use it as a model for future academic agreements," said James H. Kelly, PhD, CEO of Stem Cell Innovations.
"Our objective is make our PluriCells™ widely available to researchers, on an institution friendly basis, who can move stem cell biology forward in the US, in their own labs and without the restrictions imposed by Federal regulation."
